Integrated Solution to Address Chronic Back Pain, When It’s Needed Most
SynerFuse® is a Minnesota-based medical device company innovating the spine industry with its integrated approach to spinal fusion and chronic pain. The patented SynerFuse® procedure, Electric Transforaminal Lumbar Interbody Fusion (e-TLIF™), combines fusion with direct nerve stimulation to address chronic low back and leg pain that is unaddressed in traditional spinal fusion surgery.
There are more than 500,000 spinal fusion procedures performed annually in the United States alone. As many as 40% of cases result in chronic, residual pain following a spinal fusion surgery costing the US healthcare system $20B annually. Enrollment in the proof-of-concept study has now been completed based on early data and 15 successful e-TLIF™ procedures. The innovative e-TLIF™ procedure and custom developed device, with over 80 patents combined, is an integrated solution to address chronic low back and leg pain to reduce the need for narcotic pain management.
Current patient continuum vs. the future…
Integrated Solution
Our patent-protected spinal fusion and neuromodulation concept is intended to provide non-narcotic pain management at the point of surgery.
Patient Enrollment
Enrollment completed.
Team SynerFuse®
Our Management Team, Board of Directors, Medical Advisory Board and Strategic Advisors are experienced, proven and accomplished at bringing paradigm-shifting devices to market.
Unconventional Approach
We intend to use our patented combination of proven technologies in the SynerFuse® e-TLIF™ procedure to disrupt the spinal fusion and narcotic pain management market.
